July 8, 2024
New Delhi, India
The allotment date for the Emcure Pharmaceuticals IPO is likely to be today, July 8, 2024. As per the ‘T+3’ listing rule, share allocation is expected to be finalized, and bidders will soon be able to check their allotment status online. Market observers report that shares of Emcure Pharmaceuticals are currently available at a grey market premium (GMP) of ₹392.
Key Highlights
Emcure Pharma IPO Details:
- Allotment Date: Likely today, July 8, 2024
- Current GMP: ₹392, an increase from ₹331 over the weekend
- How to Check Allotment Status: Available on BSE and Link Intime websites
How to Check Emcure Pharma IPO Allotment Status Online
On BSE Website:
- Visit the BSE allotment status page.
- Click on ‘Equity’ under the issue type.
- Select ‘Emcure Pharmaceuticals Limited’ from the issue name dropdown.
- Enter your application number or PAN details.
- Complete the CAPTCHA by clicking ‘I am not a robot’.
- Click the ‘Search’ button.
Your allotment status will be displayed on your screen.
On Link Intime Website:
- Visit the Link Intime IPO status page.
- Select ‘Emcure Pharmaceuticals Limited’ from the dropdown menu.
- Enter your PAN details.
- Click the ‘Submit’ button.
Also Read: Currency Market Analysis July 8,2024: USDINR, GBPINR, EYRONR, JPYINR
Your allotment status will appear on your screen.
Emcure Pharma IPO Grey Market Premium (GMP)
As of today, Emcure Pharma shares are trading at a premium of ₹392 in the grey market, which is an increase of ₹61 from the weekend’s GMP of ₹331. Market observers attribute this rise to strong subscription figures and positive market sentiment.
Conclusion
With the Emcure Pharma IPO allotment expected today, investors can check their status online through the BSE and Link Intime websites. The increasing GMP indicates robust demand and positive expectations for Emcure Pharmaceuticals shares.
Disclaimer:
CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.
